Core Insights - The stock of Kangtong Medical increased by 1.91% on November 3, with a trading volume of 30.07 million yuan [1] - The company experienced a net financing outflow of 809,500 yuan on the same day, with total financing and margin trading balance reaching 40.24 million yuan [1] - Kangtong Medical's revenue for the first nine months of 2025 was 344 million yuan, a year-on-year decrease of 30.06%, and the net profit attributable to shareholders was -10.21 million yuan, a decrease of 150.92% [2] Financing and Margin Trading - On November 3, Kangtong Medical had a financing buy-in of 2.71 million yuan, with a financing balance of 40.24 million yuan, accounting for 2.57% of its market capitalization [1] - The financing balance is above the 60th percentile of the past year, indicating a relatively high level [1] - The company had no short selling activity on November 3, with a short selling balance of 2241 yuan, which is above the 80th percentile of the past year [1] Shareholder Information - As of October 31, the number of shareholders for Kangtong Medical was 7,915, an increase of 4.90% from the previous period [2] - The average number of circulating shares per shareholder decreased by 4.67% to 7,964 shares [2] - The company has distributed a total of 48.99 million yuan in dividends since its A-share listing [3] Institutional Holdings - As of September 30, 2025, the top ten circulating shareholders included Nuoan Multi-Strategy Mixed A, which holds 725,100 shares, marking it as a new shareholder [3]
港通医疗11月3日获融资买入270.65万元，融资余额4023.75万元